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Abstract 
Background: Simultaneous infection with multiple malaria parasite strains is common in high transmission areas. 
Quantifying the number of strains per host, or the multiplicity of infection (MOI), provides additional parasite indices 
for assessing transmission levels but it is challenging to measure accurately with current tools. This paper presents 
new laboratory and analytical methods for estimating the MOI of Plasmodium falciparum.
Methods: Based on 24 single nucleotide polymorphisms (SNPs) previously identified as stable, unlinked targets 
across 12 of the 14 chromosomes within P. falciparum genome, three multiplex PCRs of short target regions and 
subsequent next generation sequencing (NGS) of the amplicons were developed. A bioinformatics pipeline includ-
ing B4Screening pathway removed spurious amplicons to ensure consistent frequency calls at each SNP location, 
compiled amplicons by SNP site diversity, and performed algorithmic haplotype and strain reconstruction. The pipe-
line was validated by 108 samples generated from cultured-laboratory strain mixtures in different proportions and 
concentrations, with and without pre-amplification, and using whole blood and dried blood spots (DBS). The pipeline 
was applied to 273 smear-positive samples from surveys conducted in western Kenya, then providing results into 
StrainRecon Thresholding for Infection Multiplicity (STIM), a novel MOI estimator.
Results: The 24 barcode SNPs were successfully identified uniformly across the 12 chromosomes of P. falciparum in a 
sample using the pipeline. Pre-amplification and parasite concentration, while non-linearly associated with SNP read 
depth, did not influence the SNP frequency calls. Based on consistent SNP frequency calls at targeted locations, the 
algorithmic strain reconstruction for each laboratory-mixed sample had 98.5% accuracy in dominant strains. STIM 
detected up to 5 strains in field samples from western Kenya and showed declining MOI over time (q < 0.02), from 4.32 
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Background
Malaria infection remains a major public health problem 
in sub-tropical and tropical areas. Plasmodium falcipa-
rum is responsible for most malaria-attributed morbid-
ity and mortality [1]. Accurately and timely measuring 
of the change in P. falciparum transmission levels is not 
only important in interpretation of data from epide-
miological investigations and transmission-reducing 
intervention studies, but also is essential in the impact 
evaluation of programmatic activities on malaria trans-
mission. Traditionally, the entomological inoculation rate 
(EIR) has been used for measuring malaria transmission 
level mostly for epidemiological studies [2]. However, 
EIR is not suitable for obtaining estimates of transmis-
sion level rapidly and its accuracy has been questioned 
in some studies [3–5]. Epidemiological approaches, such 
as cohort infection incidence studies, parasite prevalence 
surveys and passive case incidence data, are frequently 
used to measure transmission levels, but cohort inci-
dence studies with relatively high precision are expen-
sive and time consuming, and other malaria metrics may 
be subject to a number of biases [3]. Moreover, several 
malaria metrics could exhibit non-linear scaling relation-
ships [3]. In pioneering work, measuring the multiplicity 
of infection (MOI, defined as the number of concurrent 
parasite strains per parasite-positive host) using molecu-
lar genotyping tools showed that MOI positively corre-
lates with endemicity [6–8] and has been considered and 
proposed as an adjunct metric for characterizing malaria 
transmission [3, 9]. MOI can be the result of multiple 
mosquito bites (superinfection), a single mosquito bite 
(co-transmission) [10, 11], or both. The MOI metric, 
assuming adequate precision, can uncover parasite strain 
populations that may enhance understanding of trans-
mission dynamics [3].
Previously established molecular assays, includ-
ing size-based polymorphic antigenic genes or neutral 
microsatellites, have limited power to measure MOI 
accurately because they cannot determine the true 
parasite haplotypes within a host [12–14]. Although 
antigen-targeted or non-antigen-targeted gene (ampli-
con) deep sequencing could produce the information 
on gene-specific MOI and improve the sensitivity of 
minor variant detection [14–16], a single-target, deep 
sequencing strategy could not reflect the genomic sig-
natures of parasite strains due to only a small genomic 
region sequenced. In addition, the gene-specific MOIs 
generated from multiple-target gene deep sequencing 
could vary even within a study [14, 16], depending on 
the different multiple targets chosen, the level of host 
immune pressure on specific antigen, and/or the dif-
ferent extent of diversity in the multiple targets either 
antigenic or non-antigenic genes.
Whole genome deep sequencing has improved MOI 
estimation at the population level by detecting genomic 
signatures and minority strains of parasites through 
newly developed analytical tools, StrainRecon [17] and 
DEploid [18]. The main difference between StrainRecon 
and DEploid is that DEploid requires a reference panel 
of strains to be provided as a prior for potential hap-
lotypes present in the sample, whereas StrainRecon, 
discussed below, requires no templates or priors. Yet 
whole genome sequencing imposes practical chal-
lenges, particularly with respect to the large volume of 
parasite-infected red blood cell sample that is needed, 
along with time and cost, which together diminish the 
feasibility for rapid MOI estimation.
Separately, a molecular barcoding tool for identifica-
tion and tracking of P. falciparum using 24 single nucle-
otide polymorphism (SNP) markers was developed by 
Daniels et al. [19] as stable, unlinked targets across 12 of 
the 14 chromosomes within the P. falciparum genome. 
Whereas this 24 SNP individual TaqMan real-time PCR 
barcode tool is used successfully in pre-elimination or 
low-endemic areas for detection of a unique finger-
print or signature for a parasite genome [20], it fails in 
environments where individuals have infections with 
multiple strains since the previously established labo-
ratory and analytical tools cannot classify haplotypes 
and provide quantitative information on the number of 
strains within a host [19, 21]. The main objective of this 
study is therefore to overcome the obstacles in using 
the identified 24 SNP barcodes for MOI analysis in 
medium/high transmission areas. Here, the laboratory 
and algorithmic challenges of performing 24 SNP bar-
code-based MOI estimation suitable for medium/high 
strains per infected person in 1996 to 4.01, 3.56 and 3.35 in 2001, 2007 and 2012, and a reduction in the proportion of 
samples with 5 strains from 57% in 1996 to 18% in 2012.
Conclusion: The combined approach of new multiplex PCRs and NGS, the unique bioinformatics pipeline and STIM 
could identify 24 barcode SNPs of P. falciparum correctly and consistently. The methodology could be applied to field 
samples to reliably measure temporal changes in MOI.
Keywords: Plasmodium falciparum, Transmission, Multiplicity of infection, Haplotype and strain, StrainRecon, MOI 
estimation, STIM
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transmission areas are addressed above. To this end, a 
complete pipeline for estimating MOI from blood was 
built, including molecular tools and numerical algo-
rithms to determine likely barcodes, haplotype and 
strain number within an individual sample, resulting in 
a tool that can be useful across different transmission 
levels.
Described below is the development and validation of 
an advanced laboratory assay and unique data process-
ing pipeline with B4Screening pathway for strain dis-
ambiguation using three multiplex PCRs followed by 
MiSeq deep sequencing based on the published panel of 
24 SNPs of P. falciparum [19]. Further validation of MOI 
estimation was conducted on field samples collected over 
time from Kenya using the recently published algorithm 
StrainRecon [17] and a novel threshold-calibrated MOI 
estimation method, StrainRecon Thresholding for Infec-
tion Multiplicity (STIM) is presented below. The meth-
ods developed in this study offer malaria researchers the 
ability to target multiple genetic loci in sufficient depth 
to link across sites based on frequency of SNP reads at 
each site using the non-template approach. The consist-
ency of these SNP frequencies determines the ability of 
the algorithm to successfully assign frequencies to haplo-
types and disentangle samples that comprise of multiple 
strains [17].
Methods
Since many different analytical methods are involved 
in the scope of this study, relevant details around each 
analysis method are provided in the corresponding sec-
tion where appropriate. In addition, stepwise workflow is 
described in each technical section.
Ethical considerations
The de-identified testing for Illumina deep sequencing 
at the CDC Malaria laboratory was determined as non-
human subjects research by US CDC. The study pro-
tocols, from which field samples were obtained, were 
reviewed and approved by the Ethics Review Committee 
of the Kenya Medical Research Institute including blood 
sample collection and use of the samples for parasite 
genotyping.
Development of multiplexing PCRs with next generation 
sequencing assay
Parasite strains and quantification
Six laboratory-cultured P. falciparum strains (D6, D10, 
7G8, RO33, V1/S, W2) representing 24 known bar-
code SNPs were used for assay development. Extraction 
of DNA from cultured parasites was performed with 
QIAamp DNA Mini Kit (QIAGEN, Germantown, MD, 
USA). DNA was quantified using a real-time PCR proto-
col described by Daniels et al. [19] with a series of diluted 
standard curve  (102–105) of the plasmid targeting a single 
copy of Pf07_0076 gene.
Preparation of mixed parasites strains
Unlike the detection limit in traditional PCR diagno-
sis, the lowest limit for detecting a minor strain in a 
mixed strain infection is compounded by both lowest 
proportion of the strain and lowest parasite concentra-
tion (density). Citrated  O+ whole blood was used for 
dilution of above quantified samples. Blood was spiked 
with  105  parasites/µl with 3 different strain combina-
tions (A: D10/D6/V1-S, B: D6/RO33/W2, C: 7G8/V1-S/
R033). Each combination was prepared to target in 3 
different proportions (1: 97.5–2–0.5%, 2: 95–4–1%, 3: 
88–10–2%, respectively). These 9 combination-propor-
tion preparations were then diluted in tenfold dilution 
series to  102  parasites/µl. Based on the designed low-
est proportion (0.5%) and lowest parasite concentration 
 (102  parasites/µl) described above, a target lowest limit 
for minor strain detection was expected at 0.5 parasite/
µl. Each dilution stage was preserved as dried blood spots 
(50 µl per spot) on Whatman 903 filter paper (DBS) (GE 
Healthcare, Westborough, MA, USA) and 50-µl liquid 
aliquots in 1.5 ml sample tubes. The liquid aliquots were 
immediately frozen at − 80 °C. The filter paper spots were 
dried overnight in a biosafety hood and were then stored 
at − 80 °C in a Ziploc bag with 4 desiccant packs (IMPA-
KCorp., Los Angeles, CA, USA) and a moisture indicator. 
A single DBS (50 µl) and equally a 50 µl of liquid aliquot 
were used for each DNA isolation using QIAamp DNA 
Mini Kits (QIAGEN).
Multiplex PCR development
The primers for 24 SNPs by individual real-time PCRs 
described by Daniels et  al. [19] were used for 3 multi-
plex PCR reactions with the addition of standard 16S 
sequencing overhang adaptor sequences [Forward over-
hang: 5′ TCG TCG GCA GCG TCA GAT GTG TAT AAG 
AGA CAG‐(locus-specific primer) and Reverse over-
hang: 5′ GTC TCG TGG GCT CGG AGA TGT GTA TAA 
GAG ACAG‐(locus-specific primer)] [22] for use in 
MiSeq library preparation. Multiplex combinations were 
designed via PrimerSelect (DNAStar Lasergene, Madi-
son, WI, USA) to minimize primer-dimers (artifacts) in 
each multiplex reaction. Multiplex combinations were 
7-way (SNPs: 2, 3, 6, 8, 10, 15, 23); 8-way (SNPs: 4, 5, 7, 
11, 12, 14, 16, 21) and 9-way (SNPs: 1, 9, 13, 17, 18, 19, 20, 
22, 24). For each multiplex reaction, a stock primer solu-
tion was made of all forward and reverse primers with a 
concentration of 100 µM each.
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Multiplex PCR reaction contained 12.5  µl 2× master 
mix Platinum Multiplex PCR supermix (ThermoFisher 
Scientific, Waltham, MA, USA), 100 nM each primer, 1 µl 
DNA template and PCR water in a 25-µl total reaction 
volume. Samples were run with 2 min of initial denatura-
tion at 95 °C, followed by 35 cycles of 30 s denaturation at 
95 °C, 1 min and 30 s annealing at 60 °C and 30 s exten-
sion at 72  °C, with a final extension at 72  °C for 10 min 
and final resting temperature of 4 °C.
Following visualization via DNA electrophoresis on a 
2% agarose gel with 3 µl of 50 bp Track-it ladder (Ther-
moFisher Scientific) to ensure amplification, the short 
PCR products of 3 multiplex PCRs were pooled together 
for a sample and purified collectively on QIAquick PCR 
purification columns (QIAGEN). The purified DNA was 
quantified using a Nano Drop 2000 instrument.
Testing with pre‑amplification (two‑step PCRs)
To evaluate the ability to amplify low frequency SNPs, 
a comparison test between one-step multiplex PCR 
described above and a pre-amplification PCR step before 
multiplex PCR with PreAmp PCR kits (ThermoFisher 
Scientific) was conducted. The pre-amplification step 
used the same primers as each individual multiplex at 
100 nM each, with 10 µl of TaqMan Preamp Master Mix 
solution, 1 µl DNA template and PCR water up to 20 µl 
total reaction volume. Following pre-amplification, prod-
ucts were diluted 1:20 and 1 µl diluents were carried over 
into the multiplex PCRs described above.
Testing with different concentration in laboratory‑cultured 
strains
To evaluate the minimum detection threshold of mul-
tiplex PCRs and the NGS (see below for detailed NGS), 
serial dilutions of P. falciparum at  102 to  105/µl from 
the different combinations and proportions of parasite 
strains were tested in triplicate. All samples with parasite 
concentration < 105/µl were run both with and without a 
pre-amplification.
Testing with different type of samples using 
laboratory‑cultured strains
Both frozen liquid blood samples (50  µl per sample) 
and DBS samples (50  µl per spot) were tested with and 
without pre-amplification. In total, final 108 samples 
generated from laboratory strains (with different combi-
nations, proportions, concentrations, and sample types) 
were tested.
Testing with field samples
Two-hundred and seventy-three smear-positive sam-
ples from 4 cross-sectional surveys in Asembo, western 
Kenya were used for this study [23–25]. Among these, 65 
samples from 1996 and 72 samples from 2001 were ran-
domly selected in children from 6 months to 5 years, and 
53 samples from 2007 and 83 samples from 2012 were 
used based on the availability of samples in individu-
als from 6  months to 20  years. Since age is known not 
to affect parasite diversity or MOI measurements when 
neutral markers, such as microsatellites and 24 SNP bar-
code, are used [20, 23, 26], it was expected that the 24 
SNP barcode-based MOI measured in this study is also 
unlikely to be influenced by age [20, 26]. The field sam-
ples were tested in the same multiplex PCR and NGS 
conditions as the laboratory-cultured mixed parasite 
strains with or without the pre-amplifications. Labora-
tory-cultured strains as positive controls and normal 
blood as negative control were used for each experimen-
tal run for the field samples.
MiSeq library preparation and run
MiSeq Libraries were prepared using a standard 16S 
Metagenomics sequencing protocol (Illumina) [22]. 
Briefly, the PCRs for attaching sequencing indexes and 
adapters were performed with the Nextera XT Index 
Primers with dual index barcodes followed by a clean-
ing process. The final libraries were analysed on Frag-
ment Analyzer for size and concentration (ng/µl). The 
libraries for all the samples were normalized to 10  nM 
by diluting in elution buffer and pooled at equal volume. 
The final 10 nM pool was diluted to 2 nM and denatured 
and diluted for loading on the Miseq flowcell. Up to 54 
barcoded samples were pooled in one library (per plate) 
using Illumina 2 × 250 bp run. On completion, sequence 
reads were filtered for read quality, base called and 
demultiplexed using bcl2fastq (v2.19). The sequencing 
results were saved for bioinformatics analysis.
Development of bioinformatics analysis pipeline 
for processing NGS data
The bioinformatics analysis pipeline developed in this 
study was to clean NGS data for consistent frequency 
calls at each SNP site across 12 chromosomes. Because 
24 SNP barcodes differ from 16S metagenomics data in 
depth of coverage and amplicon diversity, an existing 
16S bioinformatics pipeline was modified, and several 
additional data cleaning components were integrated as 
described below. This novel pathway, called B4Screening, 
involves four steps: initial adaptor trimming and clean-
ing, Bioconductor dada2 pathway, targeted removal of 
mismatched primers or probes, and a random forest clas-
sification of remaining reads. All steps are detailed below.
Data processing
Sequences were first trimmed to eliminate Illumina adap-
tor primers by CutAdapt 1.8 and cleaned by Prinseq 
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0.20.3. Quality was examined via FaQCs 1.34. Follow-
ing CutAdapt and Prinseq, sequences were loaded into 
R to use a modified Bioconductor 16S pipeline. Dada2 
(v1.6.0) was used for secondary filtering and trimming, 
error rate detection, pairing, and chimera removal. Fol-
lowing processing in the dada2 pipeline to remove bime-
ras, a second chimera removal step was performed which 
required that forward and reverse primers matched the 
same target location. The first and last 15 base pairs of 
each read were compared to the lookup table of poten-
tial primers, and the best matching primer (maximum of 
2 mismatches) was identified as the input primer. Reads 
were reverse complimented and those reads without a 
matching forward and reverse primer pair were removed. 
Matching to initial probe location from the publication 
[19] was used to evaluate whether reads matched the ref-
erence or alternative base at the SNP site. If neither refer-
ence nor alternative SNP (as designated binary) matched, 
the reads were removed. For each amplicon, reference 
and alternative probe sequences were trimmed to the 
identical length, and number of mismatches was calcu-
lated for each probe. Amplicons that had more than two 
mismatches to both probes were discarded as a spuri-
ous amplicon. Because the database included SNPs only, 
amplicon length variations greater than one base pair 
versus expected reference length were removed. The low 
frequency variants (< 0.1% of the total sequences) were 
also removed.
Matching to reference sequences
The Bioconductor pipeline was designed for 16S data, 
therefore, the assignment of genus and species was used 
as proxy for amplicons matching the correct targets in the 
genome. Each region was entered as part of a reference 
library. Genus level assignment was provided via assign-
Taxonomy with a minimum bootstrap value of 80%. Ref-
erence amplicon sequences from the P. falciparum 3D7 
were identified as exact matches for “species” assignment 
in dada2 assignSpecies. A phyloseq object was produced 
(Phyloseq version 1.22.3) incorporating SNP site and 
other relevant sample information and unique amplicons 
for all possible variants in the dataset prior to removal of 
low frequency amplicons.
Designing a random forest (RF) machine learning classifier
To address the amplicons generated by multiplex pro-
cessing in data in which sample composition is not 
known, a classifier was trained on 3/4 portion of the data 
and tested on the remaining quarter. This classifier was 
generated in caret (v 6.0.84 in R) using a random forest 
(RF) design. The classifier was provided with 4 elements: 
(1) proportion of all unique amplicons by sample; (2) pro-
portion of all unique amplicons by plate; (3) reads with 
SNP by plate; and, (4) sample reads per plate, all of which 
should be reflective of unique amplicon distribution in 
field data. Repeated tenfold cross validation (10, repeat 3) 
and features were evaluated in both the laboratory strain 
dataset and datasets in which sample characteristics are 
unknown. As a test, the classifier was also trained on two 
combinations and evaluated on a third for comparison of 
unrelated data.
Initial amplicon training labels were generated based 
on mixes of laboratory strains with known SNP locations. 
Training labels of “positive” and “negative” were based 
on three criteria. For a positive label: (1) strains had to be 
present in more than 12 samples of the 36 samples repre-
senting each combination; (2) strains had to be more than 
0.1% of the data at that SNP location; and, (3) strains had 
to change frequency with changing proportions of strains 
in models accounting for expected frequency ratio with 
MiSeq run as a random effect (using lmer in R). Failing to 
meet any of the above criteria resulted in a negative label.
Read depth and frequency determination
Following removal of all spurious amplicons, only sam-
ples with at least 16 SNP sites represented with a read 
depth of at least 500 for each SNP were retained for fre-
quency estimation. Read frequency for reference (REF) 
versus alternative (ALT) alleles was calculated by aggre-
gating all confirmed amplicon sequence variants within a 
genus designation by target SNP. To determine the influ-
ence of preprocessing and parasite density on reads per 
locus,  log10 reads per locus were modelled using random 
effects mixed models in R (lmer). Formula: ReadsPerLo-
cus = ParasiteConcentration + PreAmplification + Pro-
portions + Mixture + Plate, with a random intercept: 
Sample.
Consistency of read frequencies
To get initial point estimates for SNP read frequen-
cies in each experimental combination-mixture pairing, 
restricted regression (R package restriktor) was per-
formed per unique experimental combination. Frequency 
calls within each sample were analysed for impact of pre-
amplification or parasite concentration while controlling 
for unique biologic mixture (combination, proportion, 
sample type) using a linear model.
Strain reconstruction and haplotype analysis
A previously developed mathematical algorithm, Strain-
Recon [17], was used for identifying haplotypes and enu-
merating strains based on frequency results of individual 
24-SNP barcodes generated from NGS. Briefly, the basic 
StrainRecon algorithm accepts a vector s of SNP frequen-
cies as input and a parameter n denoting the anticipated 
number of strains. The output is twofold: a binary matrix 
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M containing n reconstructed strain barcodes, and a vec-
tor v of strain mixtures. The strains found by the algo-
rithm represent the maximum likelihood estimate of the 
original barcodes under three assumptions. First, the 
overall error from all steps of the pipeline can be mod-
elled as normally distributed (Gaussian) noise. Second, 
noise values are independent between SNP sites. Third, 
the metric minimized to optimize the solution quality is 
Mv − s2 , called the misfit. (Here, �·�2 denotes the stand-
ard Euclidean L2-norm.) Both M and v are assumed to be 
completely unknown, making this a mathematical inverse 
problem. StrainRecon models the problem as a Bayesian 
maximum-a-posteriori (MAP) estimation problem, using 
block coordinate descent to quickly converge at a solu-
tion when the number of strains n is small. The algorithm 
further provides an average (and standard deviation) over 
the entire posterior distribution of candidate solutions, 
which can be used to illustrate confidence or ambigu-
ity of each call the algorithm makes within a barcode or 
strain mixture fraction. In this paper, the StrainPycon 1.0 
[27] implementation of the StrainRecon algorithm for 
Python 3.4.3 was used for analysis. Each sample was eval-
uated for barcode sequences given the assumption that 
field samples can include up to and including 6 strains.
StrainRecon thresholding for infection multiplicity (STIM) 
algorithm
StrainRecon allows discrimination of the pattern of hap-
lotypes that are sufficiently prevalent in a sample relative 
to the experimental noise, as measured by misfit. The 
goal of this study was to create a tool that can further 
estimate the true number of parasite strain infections in a 
sample without the need for templates while being aware 
that extremely low-proportion strains in the sample are 
indistinguishable from noise. The method, therefore, 
takes each sample and runs the StrainRecon algorithm in 
a loop over number of strains n to determine the misfit 
of the MAP solution for each n. As the number of free 
parameters increases with n, the largest misfit will be 
found with n = 1, and the misfit decreases with larger n. 
In lay terms, it will always be possible to better fit the 
strains of a sample by imagining that it contained more 
haplotypes, but some of these haplotypes may be an arti-
fact of introduced variation inherent in NGS sequencing. 
The approach used in this study for determining MOI 
was to set a threshold value, called T, on the misfit value 
and to return the lowest n whose MAP estimate had mis-
fit below T. Together, the complete procedure is referred 
to as the STIM algorithm.
The upper bound of n is limited by noise levels in the 
analytical pipeline. In practice, when error rates are 
in the range of 1–3%, the upper bound of n that can be 
meaningfully processed is about 5–6 strains. Specifically, 
even under optimistic assumptions about mixture pro-
portions for strain disambiguation (which is when mix-
ture proportions are proportional to the first powers of 
2), an inverse problem barring an informative Bayes-
ian prior or a tailored noise model will be unable to dif-
ferentiate more than n = − log2 (ε) strains from noise 
level of ε > 0 . For example, at 1% error, this bound is 
n ≤ − log2 (0.01) ≈ 6.6 . Within these constraints, the 
STIM method has the crucial advantage of estimating 
MOI while not depending on any template information, 
unlike DEploid [18], for example.
Results
Sequencing coverage in laboratory strain samples
Of the 23.48 million Prinseq-cleaned, paired reads in the 
108 laboratory-generated samples, 21.47  million reads 
remained prior to evaluating with the RF classifier (see 
next subsection for development of RF classifier). The 
number of unique amplicons assigned (across all 24 loci) 
in the laboratory strain dataset dropped from 9901 fol-
lowing the standard dada2 pipeline to 360 following addi-
tional filtering for primer mismatch and probe mismatch. 
Potential unique amplicon numbers per SNP target loca-
tion in this screened set were varied, with a minimum of 
2 (SNP14, SNP18) and a maximum of 70 (SNP11).
Of these 360 unique amplicons, 51 were retained fol-



























































































































Fig. 1 Distribution of unique amplicons in laboratory strains. 
Red bar represents number of unique amplicons following dada2 
Bioconductor processing steps of B4Screening and additional 
matching-based steps, and green bar shows number of unique 
amplicons following RF classifier B4Screening steps, separated by SNP 
target location
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SNPs at the target locations (Fig. 1) and several additional 
SNPs at different locations in the amplicon. The final 
number of unique amplicons per SNP target location 
ranged from 1 to 3 in the laboratory strain data. Overall, 
21.35 million (90.9%) reads remained following exclusion 
of spurious amplicons via the RF classifier (see Addi-
tional file 1: Fig. S1). For each location, unique amplicons 
retained after RF classification were summed by target 
SNPs to generate frequencies for StrainRecon.
RF machine learning classifier development using 
laboratory strains
There were 5193 unique datapoints for classifier develop-
ment in the laboratory strain dataset, accounting for 2576 
of the 2592 potential SNP sites among all 108 samples 
(not all SNPs had > 500 reads in each sample). If the clas-
sifier was trained with 75% of the total data selected, 3881 
data values were used for training and 1312 for testing.
In the 1312 test set, all 1161 positively coded unique 
amplicons were correctly identified and all 151 negative 
unique amplicons as initially coded were also correctly 
identified. Alternatively, if a single mixed combination C 
was withheld as a test set rather than a random selection 
of unique amplicons across all data, to protect against 
inadvertent data leakage, 3369 data-samples combina-
tions were used for training and 1824 for testing. In this 
case 1587 out of 1624 positively coded unique ampli-
cons were correctly classified (sensitivity: 97.7%) while 
197 of 200 (specificity: 98.5%) negatively coded unique 
amplicons were correctly classified. Overall, the ampli-
cons classified for removal were low copy number rela-
tive to the total representation of the target region (see 
Additional file 1: Fig. S1).
When the field samples from western Kenya were pro-
cessed, the same RF classifier was used to screen viable 
amplicons.
Read depth and coverage of target SNP sites in laboratory 
strains
The proportion of samples retaining sufficient read 
depth across all SNP locations following RF classifica-
tion was evaluated. A cut-off of 500 reads was selected 
to ensure that precision would not be influenced by read 
depth. With a minimum coverage depth of 500 reads 
post-processing, SNP 16 was absent in 16 of laboratory 
samples (15%). No laboratory strain samples had fewer 
than 16 total SNPs represented, and while the fifth per-
centile number of SNPs present within a sample was 21, 
78 of 108 samples had all 24 SNPs present. With a cut-off 
of 500 reads, individual SNP read depth was lowest for 
SNP18 (2090 median read depth), and highest for SNP10 
(17,630 median read depth) (see Additional file  2: Fig. 
S2).
Relationship between read depth and sample 
characteristics
Multivariable models assessed the relationship between 
sample characteristics and read depth. Neither pro-
portion of strains in a mixture (p = 0.43), nor specific 
Fig. 2 Relationship between read depth and sample characteristics in laboratory strain mixes. a Reflects  log10 total reads by plates that contain 3 
different strain mixtures A: D10/D6/V1-S, B: D6/RO33/W2, C: 7G8/V1-S/RO33 respectively, as cited in Methods. b Reflects impact of pre-amplification 
(PA) and non-pre-amplification (NOPA), separated by parasite concentration as not all parasite concentration/pre-amplification combinations 
exist in the data. The groups that are significantly different in read depth by original parasite concentration are indicated by “g1”and “g2” symbol, 
respectively
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strain mixture (p = 0.67) was associated with read depth 
(Fig. 2a). Figure 2a also showed a low variability among 
three different processing pipelines. Parasite concen-
tration was non-linearly associated with average read 
depth [(102 = 5500,  103 = 6170,  104 = 8310,  105 = 8310 
reads/site), p < 0.0001]. Samples with  102 and  103 para-
site concentration did not differ from each other, nor 
did samples with  104 versus  105 parasite concentrations. 
However, comparisons among other pairs were signifi-
cant (emmeans, Tukey correction, p < 0.01) (Fig. 2b). Read 
depth did not significantly differ between pre-amplified 
and non-pre-amplified samples [(6460 vs. 7410 average 
reads/site), p = 0.053] (Fig.  2b). Both DBS and frozen 
blood plates yielded sufficient reads in each SNP location.
Consistency of read frequencies in laboratory strain 
samples
SNP frequency calls for unique strains must be consist-
ent within a single sample to ensure consistent bar-
code calls. Boxplots for frequencies across all parasite 
concentrations, pre-amplification and sample types 
(Fig.  3) show the full range and central tendency for 
unique-strain SNP frequencies across all conditions in 
laboratory strain data. A single site (SNP23) in Combina-
tion A mix was excluded from this analysis as the high 
proportion template appears to have both potential SNPs 
present in the original source material (see Additional 
file 3: Fig. S3).
Within a sample, a restricted regression linear model 
for proportion of reads matching the 3D7 reference 
sequence was fit with all three strains and categories 
(low, medium, high proportion), constrained to 1 (l  m, 
and restriktor packages in R) to assess consistency across 
samples prior to running strain reconstruction. Unique 
strain frequencies were not influenced by pre-amplifica-
tion (p = 1), or parasite concentration (p = 1), but differed 
by combination and strain proportion category (low/
intermediate/high).
Reconstruction of strain barcodes using laboratory strain 
mixes
Using SNP frequency calls, StrainRecon’s MAP esti-
mates of 108 laboratory strain samples were calculated, 
varying the parameter n of the number of strains to be 
reconstructed (anticipated MOI) between 1 and 5. The 
reconstructed barcodes for each sample were compared 
to ground truth barcodes intended to be mixed, counting 
the number of reference/alternate matches at SNP sites 
with read depth of at least 500.
The 72 samples from Combinations B and C contain 
three strains. The dominant strain in the 36 samples from 
Combination A consistently generated two distinct reads 
at SNP23 (see Additional file 3: Fig. S3), indicating a likely 
presence of mutation. These two distinct reads at SNP23 
were reconstructed independently, and Combination A 
samples were therefore characterized as containing four 
strains (33% of samples).
Table  1 shows that over 98.5% of the base pairs in 
the dominant “high” strains (target proportion range 
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Fig. 3 Frequencies of unique SNPs across all parasite concentrations, 
pre-amplification and sample types from laboratory strain mixes. Red 
is values with no unique strains at given SNP location, green is where 
the highest proportion strain is unique, teal where the intermediate 
proportion strain is unique and purple where the lowest proportion 
strain is unique. The estimated SNP frequency for each strain as 
generated in restriktor is represented in black dot. Combinations (A, B, 
C) were listed with proportions (1, 2, 3) as cited in Methods
Table 1 Barcode reconstruction quality with StrainRecon, varying the number of strains to be found
Columns are arranged by proportion of strain in the mixture, so the most dominant strain is called Strain 1. Non-barcode SNP sites are omitted
a Strain 4 exists only in those samples where SNP23 had a mutation
Proportion of SNP sites correctly 
reconstructed
Strain 1 (%) Strain 2 (%) Strain 3 (%) Strain  4a (%)
Anticipated MOI n = 1 98.97
Anticipated MOI n = 2 98.97 84.79
Anticipated MOI n = 3 98.70 89.25 64.64
Anticipated MOI n = 4 98.78 82.69 48.80 19.79
Anticipated MOI n = 5 98.50 77.52 47.06 19.28
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algorithm is configured to identify more strains ( n ≤ 5 ) 
than are truly mixed in the samples [17]. The “inter-
mediate” strains (target proportion range of 2–10%) 
were reconstructed at 77.5–89.3% accuracy, and the 
“low” strains in the mixtures (target proportion range 
of 0.5–2%) were reconstructed at 47.1–64.6% accu-
racy. Among these, when using parameter n = 3 (true 
mixtures in samples), the accuracy for “high” strains, 
“intermediate” strains, and “low” strains were 98.7, 
89.3 and 64.6%, respectively. Total DNA template 
material affected the ability to reconstruct barcodes, 
with percentage of correct SNP calls in the three true 
strains at 75.0% among all mixtures at  102 parasites/µl, 
80.6% at  103 parasites/µl, 88.4% at  104 parasites/µl, and 
90.6% at  105 parasites/µl.
It is noted that larger n provides more free param-
eters, thus allowing solutions to have a better fit to 
the SNP frequency vector than smaller n, even when 
n exceeds the true number of strains in a sample. In 
this latter case, the algorithm “overfits” and attempt 
to explain experimental noise in the data with extra 
low-frequency strains to score a lower misfit value 
(see Additional file 4: Fig. S4 and Additional file 5: Fig. 
S5 with detailed information using individual sample 
examples). However, the third strain (and mutated 
fourth strain for Combination A samples) in all mix-
tures had very small proportion, even less than the 
estimated noise level of the experiment (≤ 5%), which 
deteriorates the barcode reconstruction.
StrainRecon thresholding for infection multiplicity (STIM) 
algorithm
Recall that the StrainRecon method takes the number 
of anticipated strains n as input and then determines 
what barcodes and mixture vectors of n strains produce 
the best fit (lowest misfit) by minimizing noise. A natu-
ral approach for estimating the true number of strains is 
then to place a threshold on the acceptable fitness level 
and determine how many strains n StrainRecon needs to 
produce barcodes and mixture vector with sufficiently 
low misfit. This algorithm is called STIM. The STIM 
estimation method was first evaluated on synthetic data 
produced by generating 1000 barcode matrices M and 
mixture vectors v uniformly at random for each specific 
number of strains n and calculating the dot-product Mv. 
Following the StrainRecon framework [17], Gaussian 
noise with a known standard deviation γ , corresponding 
to the amalgam of errors and reads in the laboratory pipe-
line, is added to the dot-product before the resulting vec-
tor is reconstructed. Figure  4 (left) varies the threshold 
Fig. 4 STIM estimation method on synthetic data. The data was generated by creating uniformly random barcodes and mixture vectors and adding 
Gaussian noise (top: std.dev = 0.05, bottom: std.dev = 0.01) to create input vectors for StrainRecon. The graph shows the percentage of synthetic 
samples for which the MOI was correctly identified by choosing the lowest number of strains that go below the misfit threshold on the horizontal 
axis. The plots on the left show regular performance, whereas on the right StrainRecon is provided with the correct value of the mixture vector. The 
black vertical lines show lowest misfit threshold permitted by Morozov’s discrepancy principle (here the expression simplifies to SNPs
2
= 12 ), below 
which any signal is effectively better explained by noise [17]
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value T on the horizontal axis, showing that lower noise 
levels give rise to misfit thresholds where MOI can be 
discerned for a wider range of strain counts. For compar-
ison, Fig. 4 (right) shows how well STIM performs when, 
mathematically, the proportion of each strain in the mix-
ture (vector v) is ideally separated from others (by being 
proportional to powers of 2 as can be shown through 
mathematical analysis). The noise on the mixture values 
is normally distributed around a mean of 0 with stand-
ard deviation γ of either 0.05 (top row) or 0.01 (bottom 
row). Since normally distributed variables fall within two 
standard deviations from the mean 95% of the time, these 
γ values correspond to hypothetical pipelines whose 
accuracy for SNP reads are expected to lie with within 10 
and 2%, respectively, of their true values at least 95% of 
the time. The black vertical bar shows the threshold value 
suggested by Morozov’s discrepancy principle, a point 
below which data are effectively best explained by noise. 
The results show that STIM is sensitive to noise levels: 
lower underlying error rate (standard deviation of 0.01) 
allows differentiation of strain count between 1 and 5 at 
some thresholds, whereas high underlying noise (stand-
ard deviation of 0.05) is more restrictive.
Calibrating the STIM threshold
The assumption of Gaussian noise works well for in 
silico, but a rigorous model for experimental noise in 
practice is lacking. To adapt STIM for field data the 
first step was to calculate the MOI threshold T for lab-
oratory strain mixture data (108 samples) while simul-
taneously calibrating MOI values that are analytically 
predetermined. To tolerate error in the pipeline and 
the noise-to-signal uncertainty in StrainRecon, the 
threshold T was varied while conservatively measur-
ing whether samples from the laboratory strain experi-
ment were called at n = 3± 1 strains. The case for 
n = 2 accounts for mixture proportions that were so 
low (0.5–1%) relative to noise so that the correspond-
ing samples effectively have two strains. Conversely, 
n = 4 accommodates the Combination A samples in 
mixtures that had a mutation in SNP23 in one of the 
laboratory strains, thus creating 4-strain combinations 
(Additional file  3: Fig. S3). In STIM, the calibrated 
threshold of T = 1.8× 10−7 provided MOI within 
n = 3± 1 strains for 101 out of 108 laboratory-mixed 
samples (93.6%). Overestimation (n = 5) was observed 
in 7 out of 108 laboratory samples (7.4%). The results 
are delineated in Table 2. To account for any potential 
inaccuracy in the threshold choice determination, the 
final step evaluated the field results across a range of 
threshold values (see Fig. 6).
MOI in Kenyan field samples
The StrainRecon and STIM algorithms with a threshold 
of T = 1.8× 10−7 were used to evaluate field samples 
from 4 cross-sectional surveys conducted in Kenya. A 
Kruskal–Wallis H-test (non-parametric one-way analy-
sis of variance that extends the Mann–Whitney U test) 
on the MOI differing among smear-positive samples 
from 1996, 2001, 2007, and 2012 surveys was significant 
( H = 29.7 , p < 2× 10−6 ). The result suggests that the 
distribution of MOI in at least one of the years stochasti-
cally dominated another.
To determine the differences in MOI between years, 
the Conover-Imam test was carried out to compare pair-
wise stochastic dominance for all pairs. False discovery 
rate (FDR) was controlled for using the two-stage step-
up method of Benjamini, Krieger, and Yekutieli (BKR), 
which improves the power of the well-known Benjamini 
and Hochberg (BH) FDR mitigation method without 
making additional assumption [28]. The results with the 
FDR-corrected p values (q values) are shown in Table 3. 
The comparisons showed significant decrease in MOI 
( q < 0.02 ) between every pair of survey years between 
1996 and 2012 with the exception of 2007 and 2012 
( q = 0.15 ). In best fitting results from STIM, all samples 
contained either 5 or fewer strains and no sample con-
tained 6 (or more) strains above the 5% noise level resolu-
tion of STIM. Notably, strains of low proportions (≤ 5%) 
in samples are indistinguishable from pipeline noise 
in the MOI estimates. The STIM results thus suggest a 
decline from an average of 4.32 strains per infected per-
son in 1996 to 4.01, 3.56, and 3.35 in the years 2001, 2007, 
Table 2 Distribution of  MOI estimates by  STIM on  108 
laboratory-mixed samples using the  threshold 
T = 1.8× 10
−7
Estimates for the true MOI value are italicized
True MOI 1 2 3 4 5
n = 4 (Comb. A) 0 3 13 17 3
n = 3 (Comb. B) 0 4 21 11 0
n = 3 (Comb. C) 0 3 15 14 4
Table 3 Difference in MOI across years in the Kenyan field 
samples
FDR-corrected p-values (q-values) of a Conover–Imam significance tests 
for difference in MOIs across all pairs of years in the Kenyan field samples. 
Significance at q = 0.05 level is denoted by an asterisk (*)
1996 2001 2007 2012
1996 1.7× 10−2* 9.8× 10−5* 4.4× 10−7*
2001 1.7× 10−2* 1.6× 10−2* 7.0× 10−4*
2007 9.8× 10−5* 1.6× 10−2* 1.5× 10−1*
2012 4.4× 10−7* 7.0× 10−4* 1.5× 10−1
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and 2012, respectively (Fig. 5c). Figure 5d also shows that 
the fraction of samples with one strain increased from 
3% in 1996 to 17% in 2012 while the fraction of samples 
with 5 strains reduced from 57% in 1996 to 18% in 2012. 
The FDR-adjusted statistical test results for STIM are 
robust to changes in the misfit threshold parameter T 
(Fig.  6) except between 2007 and 2012 which straddles 
the q = 0.05 boundary.  
In addition to MOI, all barcodes with at least 5% pro-
portion that StrainRecon reconstructed from the samples 
across all years were unique, 878 distinct strains in total. 
This finding suggests a lack of clonality in the Asembo 
Bay area.
Since the surveys 2007 and 2012 comprised individu-
als up to 20 years of age, a potential influence of age on 
MOI was further examined. There were no significant 
correlations between MOI and age, comparing children 
of 5 years and below with older ages, in 2007 (q = 0.07) or 
2012 (q = 0.24) surveys, respectively.
In summary, the validation using field samples from 
Kenya suggests that the approach developed in this study 
could be used on the field samples for reliably recon-
structing strains in individual samples and for detecting 
changes in MOI over time.
Discussion
This study described the development of laboratory 
assays with multiplex PCRs followed by NGS, a unique 
bioinformatic process with B4Screening pathway and a 
a c
db
Fig. 5 Metrics for assessing the change in transmission level in western Kenya. a EIR in Asembo, western Kenya from 1995 to 2012. b Malaria 
prevalence in age under 5 years old with a 95% confidence interval in same area from 1996 to 2012. c MOI as estimated by the STIM algorithm 
from 1996, 2001, 2007, and 2012 surveys in same area, presented as average MOI. d Percentage of samples with different number of strains in same 
area from 1996, 2001, 2007, and 2012 surveys. EIR data and malaria prevalence data, based on smear diagnosis, were extracted from published [38] 
and unpublished (KEMRI/CDC) data. The StrainRecon and STIM algorithms with a threshold of T = 1.8× 10−7 were run for the SNP frequency data 
generated from smear-positive samples from 4 surveys in Kenya for MOI estimation
Fig. 6 FDR-adjusted significance levels of the key statistical tests 
with different STIM thresholds T. Robustness across a neighborhood 
of values around the chosen T, shown on a log–log scale. The dotted 
black vertical line is the threshold derived from laboratory data 
and was used to generate Fig. 5c, d and Table 3; the dotted blue 
horizontal line is the significance level of q = 0.05 . The strain count 
was not significantly different between 2007 and 2012 in the vicinity 
of the MOI misfit threshold used
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novel threshold-calibrated MOI estimation method capa-
ble of detecting multiple-strain infections of P. falcipa-
rum parasites in artificially mixed laboratory strains and 
field isolates. Using this pipeline, the 24 barcode SNPs 
were identified successfully and uniformly from the 12 
chromosomes of P. falciparum in a sample. The impact 
of pre-amplification, parasite concentration and strain 
proportion on the SNP frequency of mixed laboratory 
strains were evaluated. Parasite concentration within 
the tested range and pre-amplification did not influence 
the SNP frequency of strain within the same proportion, 
which allowed the evaluation of the field samples with a 
range of parasite densities with and without pre-ampli-
fication. Both DBS and frozen blood yielded sufficient 
reads in each SNP location analysed. Based on consist-
ent barcode 24 SNP frequency calls at targeted locations, 
the algorithmic reconstruction of strains for each sample 
using a novel published StrainRecon [17] reconstructed 
the barcodes of dominant strains with 98.5% accuracy. 
In field samples from western Kenya, up to 5 strains in a 
sample were identified using same tools described above 
and temporal changes in 24 SNP barcode-based MOI 
could be reliably estimated using the novel threshold-cal-
ibrated STIM method developed in this study.
Pipeline development
Multiplex PCR is a fast and cost-saving approach for 
pathogen diagnosis and genotyping [29, 30]. Three mul-
tiplex PCRs covering all 24 barcode SNPs identified 
by Daniels et  al. [19] within the P. falciparum genome 
were developed in this study. The 24 short target regions 
needed to be amplified with comparable efficiency in 
multiplex PCRs to ensure generation of sufficient SNP 
coverage at each location via NGS. The 3 optimal multi-
plex PCRs were developed through a series of optimiza-
tions and pilot testing.
The most important and challenging issue was how to 
uniformly call the 24 barcode SNP frequencies based on 
NGS data and assign these frequencies to haplotypes. 
The second, interlinked, challenge was to determine 
how many strains were represented in each sample. To 
resolve these challenges, the StrainRecon mathematical 
algorithm for strain disambiguation [17] from different 
chromosomes and different SNPs [19] was leveraged in 
this study. It is important to point out that the consist-
ency of SNP frequency calls at targeted SNP locations 
determines the ability of the StrainRecon and thus STIM 
to successfully assign these frequencies to haplotypes and 
disentangle the multiple strains within a sample and MOI 
estimation.
To maximize the consistency of SNP frequency calls 
from NGS data for haplotype assignment and strain 
reconstruction, the unique bioinformatics pipeline 
with B4Screeining pathway developed in this study first 
removed spurious amplicons introduced by sequencing. 
Initial data trimming and cleaning steps, by CutAdapt 
and Prinseq and data quality visualization via FaQCs 
prior to entry into the Bioconductor pipeline, ensured 
only sufficient quality, trimmed reads were processed. 
Without proper screening of noise, the extraneous ele-
ment could erroneously generate orders of magnitude 
more sequences than truly exist in the data. There were 
numerous low copy number amplicons that did not 
reflect true diverse amplicons removed at population 
level using the novel and sensitive RF classifier developed 
in this study.
While this novel bioinformatics pipeline currently 
applies to the described 24-SNP malaria barcoding 
scheme, the implications of data cleaning steps here indi-
cate the importance of careful evaluation of NGS out-
put in any non-template-driven systems, such as whole 
genome multi locus sequence typing (wgMLST) or other 
barcoding approaches. The majority of unique amplicons 
(yet minority of total reads) generated in the laboratory 
and subsequently removed by routine bioinformatics 
processing did not reflect intended targets. In addition, 
chimerism between multiplex PCR targets was substan-
tial in raw data. Therefore, leaving primers that are clearly 
distinct between sites on reads during the processing 
allowed a quick screen for chimeras. Incorporating this 
step prior to primer trimming also improves data quality 
and efficiency of analysis.
In the bioinformatics pipeline, where only information 
regarding known specific SNP sites (binary) was incor-
porated, the finding of multiple distinct point mutations 
per amplicon was not utilized. This latter information 
(category) can be incorporated in future work not only to 
enhance 24 SNP frequency calls but also to be useful for 
amplicon deep sequencing data analysis.
Although laboratory or clinical samples can have high 
parasite densities, field samples from population-based 
community surveys are collected largely from asympto-
matic individuals who tend to have low parasite densities. 
In addition, in high and medium transmission areas, a 
minor proportion of parasite strains in a sample is often 
undetectable using conventional molecular technologies 
[31]. Both low parasite density samples and low propor-
tion of parasite strains in a sample could increase diffi-
culty in producing consistent frequencies across all SNP 
locations due to the limited DNA template availability. 
In this study, the impact of pre-amplification, parasite 
concentration and strain proportion on consistency of 
24 SNP frequency calls were evaluated. It showed that 
SNP frequencies were not influenced by parasite con-
centration within the currently tested range or by pre-
amplification, but differed by strain proportion. It is 
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easy to envision that SNP frequency calls are entirely 
based on original DNA template diversity when noise 
and spurious amplicons from NGS are minimized using 
the unique bioinformatics developed in this study. Most 
importantly, the results have practical applications. First, 
it allows evaluation of field samples with a range of para-
site densities, with and without pre-amplification. Sec-
ond, pre-amplification allows evaluation of samples that 
have insufficient parasite concentration for analysis of 
diversity, but sufficient concentration to amplify with-
out this step. Critically, NGS is sensitive for detection of 
low frequency SNPs in a sample [32, 33]. Compared to 
existing conventional molecular tools where minor para-
site proportion below 10–30% in a sample were generally 
undetectable [9, 34–36], the tools developed in this study 
detected the barcodes of dominant strain with 98.5% 
accuracy and the proportion of parasite strains ranging 
from 2 to 10% in a sample with accuracy between 77.5 
and 89.3%. Although the target lowest limit for minor 
strain detection was designed at 0.5  parasite/µl (see 
second subsection for laboratory assay development in 
Methods), this study did not attain such a fine level of 
resolution due to the inaccuracy observed at lower pro-
portions (0.5–2%) of strains, specifically that as the strain 
proportion decreases, the ability to accurately detect the 
minor strain diminishes. This lower bound is influenced 
by both background noise level in the current analysis 
pipeline and the low DNA copy number of minor strains 
in the sample, decreasing expected precision. Never-
theless, the results from this study showed a substantial 
improvement in sensitivity for detecting minor parasite 
populations in a sample, particularly those above 5% pro-
portion, with acceptable precision. While deep sequenc-
ing of individual targeted antigenic genes also provides 
ability to detect gene-specific minor variants in a sample, 
the estimates in the highly selected genes might not rep-
resent true genomic signatures of parasites [14, 15, 37] 
and may offer limited temporal and geographic discrimi-
nation between parasite populations [15].
The STIM algorithm for assessing MOI based on SNP 
read frequencies relies crucially on noise levels. Highly 
variable input in a noisy pipeline may cause MOI to be 
overestimated by confusing noise with true signal in 
reconstruction. A threshold was placed on MOI mis-
fit, and calibrated by balancing the false negative rate 
of the strain reconstruction quality of StrainRecon on 
the known laboratory samples to the false positive rate 
and number of strains estimated. The same threshold 
was then used for running STIM on field data under the 
assumption that most noise would be from the pipeline 
steps against which the threshold already accounted. 
Importantly, the trends and conclusions from the field 
continue to hold even if the true threshold for this was 
slightly shifted relative to the one determined by the 
laboratory strain setting. In other words, MOI value 
estimated by STIM is subject to noise, whereas tempo-
ral changes in MOI as estimated by STIM are resilient 
to such noise. A large study across geographic regions is 
ongoing to examine the robustness of the STIM method 
in the field as well as potential needs for further calibra-
tion of the proposed threshold with a richer set of artifi-
cial strain mixtures.
Field results
MOI has only recently been used as a metric for malaria 
transmission. Therefore, the EIR and malaria prevalence 
in children 5  years old and younger from same study 
area were obtained from 1995–1996 to 2012 (Fig. 5a, b, 
data extracted from both published [38] and unpublished 
KEMRI/CDC data) for side-by-side comparison with 
the MOI estimated from current study (Fig.  5c, d). The 
results show that the EIR sharply declined between 1995 
and 2001 and remained low, even as malaria prevalence 
gradually decreased between 1996 and 2007, then reach-
ing a plateau between 2007 and 2012. In comparison, the 
average MOI gradually declined over time and the per-
centage of samples with 5 strains dropped from 57% in 
1996 to 18% in 2012 (during which period the proportion 
of one-strain samples increased). Since there was no cor-
relation between MOI and age, the decline in MOI over 
time is unlikely to be confounded by host age [20]. Over-
all, the decreases in both average MOI and proportion of 
samples with 5 strains over time are in tandem with the 
decline in EIR and malaria prevalence; but the turning 
points are different. Specifically, MOI shows slow reduc-
tion, EIR has a sharp decline, and malaria prevalence 
stagnates from 2007 to 2012. This suggests a non-linear 
scaling relationship among the three malaria metrics 
[3]. The reasons behind the slow reduction in MOI are 
unclear; the large number of distinct strains detected 
in the area may play a role (878 distinct strains at least 
5% proportion were detected in total and are reported 
in Results). Nevertheless, the MOI, which provides the 
information of strain numbers within a host, is a higher 
resolution parasite index compared with the malaria 
prevalence index and it might represent true transmis-
sion level. A further study of the parasite strain popu-
lation size and strain relatedness is needed using this 
dataset.
The tools developed in this study advance both the esti-
mation of number of strains within a host but also the 
number of strains at a population level, enhancing the 
resolution for MOI estimation. This advantage is par-
ticularly obvious compared to the original Taqman PCR 
24 SNP barcode assay and COIL analysis for complexity 
of infection (COI) estimation in which monomorphic 
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or polymorphic genotypes within each sample are esti-
mated [19–21]. Taken together, the combined approach 
established in this study could be used for MOI estima-
tion, particularly for temporal changes in MOI in regions 
with medium to high transmission levels. A large-scale 
validation study is being conducted using samples from 
different malaria countries/regions with heterogeneous 
transmission intensity.
Conclusion
This study demonstrated that the combined approach of 
new multiplex PCRs, NGS and the unique bioinformatics 
pipeline developed in this study, together with the pre-
viously published StrainRecon algorithm, could identify 
prominent 24 barcode SNPs correctly and consistently 
across 12 of chromosomes of P. falciparum. Coupled with 
the novel threshold-calibrated MOI estimation method 
STIM, the proposed approach in this study provides a 
sensitive and high-resolution MOI estimator that could 
be used on field samples to measure temporal changes 
in MOI and to provide additional parasite indices for 
interpreting transmissions. The combined approach can 
potentially be used to study MOI in malaria clinical man-
ifestations and to evaluate impact of interventions on 
transmission reduction for programme purpose. The util-
ity of StrainRecon with the 24 SNP advanced laboratory 
tools and unique bioinformatics pipeline deserves further 
exploration for distinguishing recrudescence from re-
infection in drug trials. Such tools can be further geared 
to tracking of imported malaria cases. The pseudocode 
for B4Screening pathway and STIM program code are 
available for download online at: https ://www.ymsir .com/
stim/.
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Additional file 1: Figure S1. RF classification using laboratory strains. 
Figure shows proportion of each unique amplicon relative to all amplicons 
from the targeted region on a plate from all laboratory strain samples 
based on RF classifier (when random selection determined the training 
set). X axis is the  log10 count of SNP-specific reads in a Miseq run and y 
axis is  log10 count of unique amplicon-specific reads in that individual run. 
Red points are amplicons classified as negative (False) for exclusion while 
green points are amplicons classified as positive (True) for further SNP 
frequency analysis. 
Additional file 2: Figure S2. Depth of coverage across loci in laboratory 
strains.  Log10 reads per SNP target location in laboratory strain data, from 
1 to 24 IQR and outliers using a minimum threshold of 500 reads for a 
sample to be included. Green dots and right Y axis represent proportion of 
samples missing a value at each SNP site. 
Additional file 3: Figure S3. Plot SNP23 from Combination A mixes. Plot 
SNP23 from Combination A mixes was made separately from all other 
SNPs. Data is also separated by source material (DBS and frozen blood 
samples). Within each mixture, left to right, the colors are: blue—all strains 
identical, orange—dominant strain unique, green—intermediate strain 
unique, yellow—low strain unique, and gray—SNP23 in Combination A 
mixes. A pilot experiment was also conducted using a different culture 
source, and this difference at SNP23 was not observed. Based on the con-
sistency among all other SNP sites and the difference between parasite 
batches, SNP23 from Combination A was excluded from the Fig. 3 analysis 
concerning two distinct SNP reads. 
Additional file 4: Figure S4. StrainRecon reconstruction on laboratory-
mixed samples. Ground truth of barcodes (first row in each figure), the 
MAP estimate of the reconstruction matrix M and mixture vector v 
(second row), and the mean (third row) and standard deviation (fourth 
row) of the posterior density of candidate (M, v) solutions. Each block 
contains one row for each strain, ordered by decreasing frequency from 
top, with a SNP cell color ranging from purple (fraction of 0) to bright 
yellow (fraction of 1). Each reconstruction is shown as the input parameter 
n (of the number of strains) is varied from n = 1 and 4 (row-major order) 
to be reconstructed in StrainRecon on the B_24NOPA_DBS sample. The 
dominant strain is captured perfectly and with high confidence by con-
sidering the posterior statistics. The algorithm has difficulty reconstructing 
the other two less-prevalent strains, since their target range of < 4% is low 
relative to the experimental noise levels seen in the pipeline. 
Additional file 5: Figure S5. StrainRecon reconstruction on laboratory-
mixed samples given advance knowledge of n = 3 strains. Ground truth of 
barcodes (first row in each figure), the MAP estimate of the reconstruction 
matrix M and mixture vector v (second row), and the mean (third row) and 
standard deviation (fourth row) of the posterior density of candidate (M, v) 
solutions. Each block contains one row for each strain, ordered by decreas-
ing frequency from top, with a SNP cell color ranging from purple (fraction 
of 0) to bright yellow (fraction of 1). The figure showcases the algorithm 
outputs with n = 3 strains on a variety of samples and mixtures, including 
cases of accurate and unique strain reconstruction (such as B33_PA_DBS).
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